Loading...

TransCode Therapeutics, Inc.

RNAZ•NASDAQ
Healthcare
Biotechnology
$11.74
$0.74(6.73%)

TransCode Therapeutics, Inc. (RNAZ) Stock Chart & Performance Analysis

Explore TransCode Therapeutics, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
4.48%
5-Day Change
-14.04%
1-Month Change
1063.80%
3-Month Change
386.10%
6-Month Change
-33.76%
Year-to-Date (YTD) Change
351.67%
1-Year Change
-24.58%
3-Year Change
-99.98%
5-Year Change
-99.99%
All-Time (Max) Change
-99.99%

Analyzing TransCode Therapeutics, Inc. (RNAZ) Trends Across Multiple Time Frames

TransCode Therapeutics, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. TransCode Therapeutics, Inc. stock shows 4.48% 1-day change, indicating immediate volatility, while its 5-day change of -14.04% suggests a broader trend. Over a 1-month period, a 1063.80% rise could signal a pushback, whereas a 3-month rise of 386.10% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -33.76% and a YTD rise of 351.67% might concern investors, but a 1-year loss of -24.58% and a 3-year drop of -99.98% could indicate resilience. The 5-year surge of -99.99% highlights weak historical growth, while the all-time return of -99.99% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;